These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 4695378)

  • 1. Effect of pindolol, a beta receptor antagonist, in hyperthyroidism.
    Schelling JL; Scazziga B; Dufour RJ; Milinkovic N; Weber AA
    Clin Pharmacol Ther; 1973; 14(2):158-64. PubMed ID: 4695378
    [No Abstract]   [Full Text] [Related]  

  • 2. Pindolol: a comparison with other antihypertensive drugs and a double-blind placebo trial.
    Waal-Manning HJ; Simpson FO
    N Z Med J; 1974 Aug; 80(522):151-7. PubMed ID: 4608769
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of hypertension with a new beta-adrenergic blocking agent, pindolol (Viskén)].
    Persson I; Ulrich J
    Ugeskr Laeger; 1973 May; 135(20):968-70. PubMed ID: 4755952
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of hypertension with a new beta-blocking agent, pindolol (Visken).
    Persson I; Ulrich J
    Eur J Clin Pharmacol; 1973 Dec; 6(4):217-9. PubMed ID: 4591149
    [No Abstract]   [Full Text] [Related]  

  • 5. Separate and combined effects of pindolol and isosorbide dinitrate in standardized exercise tests of patients with angina pectoris.
    Zetterquist S; Furberg C; Ringqvist I; Söderholm B
    Curr Ther Res Clin Exp; 1975 Feb; 17(2):139-48. PubMed ID: 803427
    [No Abstract]   [Full Text] [Related]  

  • 6. [Results obtained with a new beta-blockader, pindolol, in 40 patients with thyroid diseases].
    Laroche C; Caquet R; Remy JM
    Ann Endocrinol (Paris); 1973; 34(2):236-8. PubMed ID: 4745284
    [No Abstract]   [Full Text] [Related]  

  • 7. Propranolol and LB 46 (prinodolol) in angina pectoris. A comparative long-term ergometric study.
    Arstila M; Kallio V; Wendelin H
    Ann Clin Res; 1973 Apr; 5(2):91-100. PubMed ID: 4201295
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of essential hypertension with pindolol and clopamide: problems arising from a combined beta blocker and diuretic therapy.
    Rosenfeld JB; Traub YM; Cohen L
    Curr Ther Res Clin Exp; 1974 Aug; 16(8):786-97. PubMed ID: 4217245
    [No Abstract]   [Full Text] [Related]  

  • 9. A double blind study of Visken LB-46, in the treatment of angina pectoris.
    Nair DV
    Indian Heart J; 1972 Jun; 24():Suppl 1:183-91. PubMed ID: 4581426
    [No Abstract]   [Full Text] [Related]  

  • 10. Pindolol in hypertension: a double-blind trial.
    Feltham PM; Watson OF; Peel JS; Dunlop DJ; Turner AS
    N Z Med J; 1972 Sep; 76(484):167-71. PubMed ID: 4564997
    [No Abstract]   [Full Text] [Related]  

  • 11. Pindolol and hyperthyroidism.
    Abadie E; Leclercq JF; Passa P
    N Engl J Med; 1983 Sep; 309(13):795. PubMed ID: 6888460
    [No Abstract]   [Full Text] [Related]  

  • 12. [The antihypertensive action of the beta adrenergic blocking agent Visken (pindolol, LB 46) in mild and moderate hypertension].
    Török E; Jávor T; Szám I; Gábor G
    Orv Hetil; 1976 Mar; 117(10):593-8. PubMed ID: 1250586
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of hypertension with the beta-receptor-antagonist pindolol (Viskèn). A comparison with chlorthalidone (Hygroton)].
    Schaffalitzky de Muckadel ; Gyntelberg F
    Ugeskr Laeger; 1973 May; 135(20):971-4. PubMed ID: 4585570
    [No Abstract]   [Full Text] [Related]  

  • 14. [Value of a beta-blocking drug in prolonged treatment of hyperthyroidism and in the triiodothyronine inhibition assay].
    Jaffiol C; Djabri M; Baldet L; Mirouze J
    Therapeutique; 1973 Feb; 49(2):111-4. PubMed ID: 4741003
    [No Abstract]   [Full Text] [Related]  

  • 15. [Antihypertensive therapy with pindolol--comparison between 2 doses and a single dose per day].
    Jacobsson KA
    Lakartidningen; 1976 Jul; 73(28-29):2500-1. PubMed ID: 781431
    [No Abstract]   [Full Text] [Related]  

  • 16. Oral pindolol in acute evolving myocardial infarction.
    O'Rourke MF; Baron D; Washington H; Sammel N; Le Cheminant D
    Aust N Z J Med; 1979 Aug; 9(4):408-11. PubMed ID: 41510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adrenergic beta-receptor blockade in essential hypertension: a comparison between pindolol (Visken) and propranolol (Inderal).
    Bjerle P; Jacobsson KA; Agert G
    Curr Ther Res Clin Exp; 1975 Sep; 18(3):387-94. PubMed ID: 241607
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of long-term administration of Pindolol (LB-46, Visken) in essential circulatory hyperkinesis. A double-blind, cross-over study.
    Békés M; Polák G; Istvánffy M; Matos L; Rausch J; Török E
    Int J Clin Pharmacol; 1974 Mar; 9(2):87-92. PubMed ID: 4208032
    [No Abstract]   [Full Text] [Related]  

  • 19. Twice-daily pindolol and alprenolol in essential hypertension of moderate severity.
    Hartikainen M; Heikkilä J
    Ann Clin Res; 1976 Apr; 8(2):85-92. PubMed ID: 779590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The cardiotropic effect of the beta receptor blockader Prindolol].
    Fiegel G
    Med Welt; 1975 Oct; 26(43):1989-9. PubMed ID: 1196090
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.